EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fluorescent Activity-Based Probe To Image and Inhibit Factor XIa Activity in Human Plasma

Sylwia Modrzycka, Sonia Kołt, Ty E Adams, Stanisław Potoczek, James A Huntington, Paulina Kasperkiewicz iD, Marcin Drąg iD

Journal of Medicinal Chemistry · 2023

DOI: 10.1021/acs.jmedchem.2c00845 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Sylwia Modrzycka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Biology and Bioimaging, Faculty of Chemistry, Wrocław University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370 …. Hauptthemen laut MEDLINE: Factor XIa, Thrombosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund, Fundacja na rzecz Nauki Polskiej.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anticoagulation therapy is a mainstay of the treatment of thrombotic disorders; however, conventional anticoagulants trade antithrombotic benefits for bleeding risk. Factor (f) XI deficiency, known as hemophilia C, rarely causes spontaneous bleeding, suggesting that fXI plays a limited role in hemostasis. In contrast, individuals with congenital fXI deficiency display a reduced incidence of ischemic stroke and venous thromboembolism, indicating that fXI plays a role in thrombosis. For these reasons, there is intense interest in pursuing fXI/factor XIa (fXIa) as targets for achieving antithrombotic benefit with reduced bleeding risk. To obtain selective inhibitors of fXIa, we employed libraries of natural and unnatural amino acids to profile fXIa substrate preferences. We developed chemical tools for investigating fXIa activity, such as substrates, inhibitors, and activity-based probes (ABPs). Finally, we demonstrated that our ABP selectively labels fXIa in the human plasma, making this tool suitable for further studies on the role of fXIa in biological samples.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Factor XIaThrombosisHumansFibrinolytic AgentsHemostasisAnticoagulantsFactor XI

Substanzen

Factor XIaFibrinolytic AgentsAnticoagulantsFactor XI

Autor:innen und Institutionen

  • Department of Chemical Biology and Bioimaging, Faculty of Chemistry, Wrocław University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland.
  • Department of Haematology, Cambridge Institute for Medical Research, University of Cambridge, The Keith Peters Building, Hills Road, Cambridge CB2 0XY, U.K.
  • Department of Haematology, Blood Neoplasms, and Bone Marrow Transplantation, Wrocław Medical University, Pasteura 1, 50-367 Wrocław, Poland.

ORCID-Profile: Paulina Kasperkiewicz, Marcin Drąg

Förderung

  • European Regional Development Fund
  • Fundacja na rzecz Nauki Polskiej

Zitieren

APA

Modrzycka, S., Kołt, S., Adams, T. E., Potoczek, S., Huntington, J. A., Kasperkiewicz, P., & Drąg, M. (2023). Fluorescent Activity-Based Probe To Image and Inhibit Factor XIa Activity in Human Plasma. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c00845

Vancouver

Modrzycka S, Kołt S, Adams TE, Potoczek S, Huntington JA, Kasperkiewicz P, et al. Fluorescent Activity-Based Probe To Image and Inhibit Factor XIa Activity in Human Plasma. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.2c00845

BibTeX
@article{Modrzycka2023,
  author = {Modrzycka, Sylwia and Kołt, Sonia and Adams, Ty E and Potoczek, Stanisław and Huntington, James A and Kasperkiewicz, Paulina and Drąg, Marcin},
  title = {Fluorescent Activity-Based Probe To Image and Inhibit Factor XIa Activity in Human Plasma},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  doi = {10.1021/acs.jmedchem.2c00845}
}
Kostenlos starten →